APA (7th ed.) Citation

Outtier, A., & Ferrante, M. (2025). Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases. Digestive Diseases & Sciences, 70(1), 17. https://doi.org/10.1007/s10620-024-08772-4

Chicago Style (17th ed.) Citation

Outtier, An, and Marc Ferrante. "Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases." Digestive Diseases & Sciences 70, no. 1 (2025): 17. https://doi.org/10.1007/s10620-024-08772-4.

MLA (9th ed.) Citation

Outtier, An, and Marc Ferrante. "Needle or Drip?—Real-World Comparison of Intravenous to Subcutaneous Infliximab and Vedolizumab in the Management of Inflammatory Bowel Diseases." Digestive Diseases & Sciences, vol. 70, no. 1, 2025, p. 17, https://doi.org/10.1007/s10620-024-08772-4.